
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Aciclovir will have significant change from previous year. By the most conservative estimates of global Aciclovir market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Aciclovir market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Aciclovir market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Aciclovir, covering the supply chain analysis, impact assessment to the Aciclovir market size growth rate in several scenarios, and the measures to be undertaken by Aciclovir companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Generic
Patent
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Greater Pharma
Reman Drug
LBS Labs
Lex Ano
Salutas
GlaxoSmithKline
Stada Nordic
Novartis
Cimed Industria de Medicamentos
Teva
Wockhardt
Aliud
Takata Pharmaceutical
L.E.T.I.
Shiono Kemikaru
Choseido Pharmaceutical
Apotex
Towa Yakuhin
Nichi-Iko Pharmaceutical
Amneal Pharma
Pfizer
Orion Pharma
Laboratoires Servier
Sanofi
Arrow
Mylan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Aciclovir consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Aciclovir market by identifying its various subsegments.
Focuses on the key global Aciclovir manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Aciclovir with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Aciclovir submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Aciclovir?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Aciclovir Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aciclovir Consumption 2015-2025
2.1.2 Aciclovir Consumption CAGR by Region
2.2 Aciclovir Segment by Type
2.2.1 Generic
2.2.2 Patent
2.3 Aciclovir Consumption by Type
2.3.1 Global Aciclovir Consumption Market Share by Type (2015-2020)
2.3.2 Global Aciclovir Revenue and Market Share by Type (2015-2020)
2.3.3 Global Aciclovir Sale Price by Type (2015-2020)
2.4 Aciclovir Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Aciclovir Consumption by Application
2.5.1 Global Aciclovir Consumption Market Share by Type (2015-2020)
2.5.2 Global Aciclovir Value and Market Share by Type (2015-2020)
2.5.3 Global Aciclovir Sale Price by Type (2015-2020)
3 Global Aciclovir by Company
3.1 Global Aciclovir Sales Market Share by Company
3.1.1 Global Aciclovir Sales by Company (2018-2020)
3.1.2 Global Aciclovir Sales Market Share by Company (2018-2020)
3.2 Global Aciclovir Revenue Market Share by Company
3.2.1 Global Aciclovir Revenue by Company (2018-2020)
3.2.2 Global Aciclovir Revenue Market Share by Company (2018-2020)
3.3 Global Aciclovir Sale Price by Company
3.4 Global Aciclovir Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Aciclovir Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Aciclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Aciclovir by Regions
4.1 Aciclovir by Regions
4.2 Americas Aciclovir Consumption Growth
4.3 APAC Aciclovir Consumption Growth
4.4 Europe Aciclovir Consumption Growth
4.5 Middle East & Africa Aciclovir Consumption Growth
5 Americas
5.1 Americas Aciclovir Consumption by Countries
5.1.1 Americas Aciclovir Consumption by Countries (2015-2020)
5.1.2 Americas Aciclovir Value by Countries (2015-2020)
5.2 Americas Aciclovir Consumption by Type
5.3 Americas Aciclovir Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Aciclovir Consumption by Regions
6.1.1 APAC Aciclovir Consumption by Regions (2015-2020)
6.1.2 APAC Aciclovir Value by Regions (2015-2020)
6.2 APAC Aciclovir Consumption by Type
6.3 APAC Aciclovir Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Aciclovir by Countries
7.1.1 Europe Aciclovir Consumption by Countries (2015-2020)
7.1.2 Europe Aciclovir Value by Countries (2015-2020)
7.2 Europe Aciclovir Consumption by Type
7.3 Europe Aciclovir Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Aciclovir by Countries
8.1.1 Middle East & Africa Aciclovir Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Aciclovir Value by Countries (2015-2020)
8.2 Middle East & Africa Aciclovir Consumption by Type
8.3 Middle East & Africa Aciclovir Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Aciclovir Distributors
10.3 Aciclovir Customer
11 Global Aciclovir Market Forecast
11.1 Global Aciclovir Consumption Forecast (2021-2025)
11.2 Global Aciclovir Forecast by Regions
11.2.1 Global Aciclovir Forecast by Regions (2021-2025)
11.2.2 Global Aciclovir Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Aciclovir Forecast by Type
11.8 Global Aciclovir Forecast by Application
12 Key Players Analysis
12.1 Greater Pharma
12.1.1 Company Information
12.1.2 Aciclovir Product Offered
12.1.3 Greater Pharma Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Greater Pharma Latest Developments
12.2 Reman Drug
12.2.1 Company Information
12.2.2 Aciclovir Product Offered
12.2.3 Reman Drug Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Reman Drug Latest Developments
12.3 LBS Labs
12.3.1 Company Information
12.3.2 Aciclovir Product Offered
12.3.3 LBS Labs Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 LBS Labs Latest Developments
12.4 Lex Ano
12.4.1 Company Information
12.4.2 Aciclovir Product Offered
12.4.3 Lex Ano Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Lex Ano Latest Developments
12.5 Salutas
12.5.1 Company Information
12.5.2 Aciclovir Product Offered
12.5.3 Salutas Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Salutas Latest Developments
12.6 GlaxoSmithKline
12.6.1 Company Information
12.6.2 Aciclovir Product Offered
12.6.3 GlaxoSmithKline Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 Stada Nordic
12.7.1 Company Information
12.7.2 Aciclovir Product Offered
12.7.3 Stada Nordic Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Stada Nordic Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Aciclovir Product Offered
12.8.3 Novartis Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Cimed Industria de Medicamentos
12.9.1 Company Information
12.9.2 Aciclovir Product Offered
12.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Cimed Industria de Medicamentos Latest Developments
12.10 Teva
12.10.1 Company Information
12.10.2 Aciclovir Product Offered
12.10.3 Teva Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Teva Latest Developments
12.11 Wockhardt
12.11.1 Company Information
12.11.2 Aciclovir Product Offered
12.11.3 Wockhardt Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Wockhardt Latest Developments
12.12 Aliud
12.12.1 Company Information
12.12.2 Aciclovir Product Offered
12.12.3 Aliud Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aliud Latest Developments
12.13 Takata Pharmaceutical
12.13.1 Company Information
12.13.2 Aciclovir Product Offered
12.13.3 Takata Pharmaceutical Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Takata Pharmaceutical Latest Developments
12.14 L.E.T.I.
12.14.1 Company Information
12.14.2 Aciclovir Product Offered
12.14.3 L.E.T.I. Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 L.E.T.I. Latest Developments
12.15 Shiono Kemikaru
12.15.1 Company Information
12.15.2 Aciclovir Product Offered
12.15.3 Shiono Kemikaru Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Shiono Kemikaru Latest Developments
12.16 Choseido Pharmaceutical
12.16.1 Company Information
12.16.2 Aciclovir Product Offered
12.16.3 Choseido Pharmaceutical Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Choseido Pharmaceutical Latest Developments
12.17 Apotex
12.17.1 Company Information
12.17.2 Aciclovir Product Offered
12.17.3 Apotex Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Apotex Latest Developments
12.18 Towa Yakuhin
12.18.1 Company Information
12.18.2 Aciclovir Product Offered
12.18.3 Towa Yakuhin Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Towa Yakuhin Latest Developments
12.19 Nichi-Iko Pharmaceutical
12.19.1 Company Information
12.19.2 Aciclovir Product Offered
12.19.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Nichi-Iko Pharmaceutical Latest Developments
12.20 Amneal Pharma
12.20.1 Company Information
12.20.2 Aciclovir Product Offered
12.20.3 Amneal Pharma Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Amneal Pharma Latest Developments
12.21 Pfizer
12.21.1 Company Information
12.21.2 Aciclovir Product Offered
12.21.3 Pfizer Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Pfizer Latest Developments
12.22 Orion Pharma
12.22.1 Company Information
12.22.2 Aciclovir Product Offered
12.22.3 Orion Pharma Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Orion Pharma Latest Developments
12.23 Laboratoires Servier
12.23.1 Company Information
12.23.2 Aciclovir Product Offered
12.23.3 Laboratoires Servier Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Laboratoires Servier Latest Developments
12.24 Sanofi
12.24.1 Company Information
12.24.2 Aciclovir Product Offered
12.24.3 Sanofi Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Sanofi Latest Developments
12.25 Arrow
12.25.1 Company Information
12.25.2 Aciclovir Product Offered
12.25.3 Arrow Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Arrow Latest Developments
12.26 Mylan
12.26.1 Company Information
12.26.2 Aciclovir Product Offered
12.26.3 Mylan Aciclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.26.4 Main Business Overview
12.26.5 Mylan Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Aciclovir Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Aciclovir Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Aciclovir Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Generic
Table 7. Major Players of Patent
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Aciclovir Consumption Market Share by Type (2015-2020)
Table 10. Global Aciclovir Revenue by Type (2015-2020) ($ million)
Table 11. Global Aciclovir Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Aciclovir Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Aciclovir Consumption Market Share by Application (2015-2020)
Table 15. Global Aciclovir Value by Application (2015-2020)
Table 16. Global Aciclovir Value Market Share by Application (2015-2020)
Table 17. Global Aciclovir Sale Price by Application (2015-2020)
Table 18. Global Aciclovir Sales by Company (2017-2019) (K Units)
Table 19. Global Aciclovir Sales Market Share by Company (2017-2019)
Table 20. Global Aciclovir Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Aciclovir Revenue Market Share by Company (2017-2019)
Table 22. Global Aciclovir Sale Price by Company (2017-2019)
Table 23. Global Aciclovir Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Aciclovir Products Offered
Table 25. Aciclovir Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Aciclovir Consumption by Regions 2015-2020 (K Units)
Table 27. Global Aciclovir Consumption Market Share by Regions 2015-2020
Table 28. Global Aciclovir Value by Regions 2015-2020 ($ Millions)
Table 29. Global Aciclovir Value Market Share by Regions 2015-2020
Table 30. Americas Aciclovir Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Aciclovir Consumption Market Share by Countries (2015-2020)
Table 32. Americas Aciclovir Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Aciclovir Value Market Share by Countries (2015-2020)
Table 34. Americas Aciclovir Consumption by Type (2015-2020) (K Units)
Table 35. Americas Aciclovir Consumption Market Share by Type (2015-2020)
Table 36. Americas Aciclovir Consumption by Application (2015-2020) (K Units)
Table 37. Americas Aciclovir Consumption Market Share by Application (2015-2020)
Table 38. APAC Aciclovir Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Aciclovir Consumption Market Share by Countries (2015-2020)
Table 40. APAC Aciclovir Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Aciclovir Value Market Share by Regions (2015-2020)
Table 42. APAC Aciclovir Consumption by Type (2015-2020) (K Units)
Table 43. APAC Aciclovir Consumption Market Share by Type (2015-2020)
Table 44. APAC Aciclovir Consumption by Application (2015-2020) (K Units)
Table 45. APAC Aciclovir Consumption Market Share by Application (2015-2020)
Table 46. Europe Aciclovir Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Aciclovir Consumption Market Share by Countries (2015-2020)
Table 48. Europe Aciclovir Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Aciclovir Value Market Share by Countries (2015-2020)
Table 50. Europe Aciclovir Consumption by Type (2015-2020) (K Units)
Table 51. Europe Aciclovir Consumption Market Share by Type (2015-2020)
Table 52. Europe Aciclovir Consumption by Application (2015-2020) (K Units)
Table 53. Europe Aciclovir Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Aciclovir Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Aciclovir Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Aciclovir Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Aciclovir Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Aciclovir Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Aciclovir Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Aciclovir Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Aciclovir Consumption Market Share by Application (2015-2020)
Table 62. Aciclovir Distributors List
Table 63. Aciclovir Customer List
Table 64. Global Aciclovir Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Aciclovir Consumption Market Forecast by Regions
Table 66. Global Aciclovir Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Aciclovir Value Market Share Forecast by Regions
Table 68. Global Aciclovir Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Aciclovir Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Aciclovir Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Aciclovir Value Market Share Forecast by Type (2021-2025)
Table 72. Global Aciclovir Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Aciclovir Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Aciclovir Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Aciclovir Value Market Share Forecast by Application (2021-2025)
Table 76. Greater Pharma Product Offered
Table 77. Greater Pharma Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Greater Pharma Main Business
Table 79. Greater Pharma Latest Developments
Table 80. Greater Pharma Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 81. Reman Drug Product Offered
Table 82. Reman Drug Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Reman Drug Main Business
Table 84. Reman Drug Latest Developments
Table 85. Reman Drug Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 86. LBS Labs Product Offered
Table 87. LBS Labs Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. LBS Labs Main Business
Table 89. LBS Labs Latest Developments
Table 90. LBS Labs Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 91. Lex Ano Product Offered
Table 92. Lex Ano Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Lex Ano Main Business
Table 94. Lex Ano Latest Developments
Table 95. Lex Ano Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 96. Salutas Product Offered
Table 97. Salutas Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Salutas Main Business
Table 99. Salutas Latest Developments
Table 100. Salutas Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Product Offered
Table 102. GlaxoSmithKline Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 106. Stada Nordic Product Offered
Table 107. Stada Nordic Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 108. Stada Nordic Main Business
Table 109. Stada Nordic Latest Developments
Table 110. Stada Nordic Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Novartis Product Offered
Table 112. Novartis Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Novartis Main Business
Table 114. Novartis Latest Developments
Table 115. Novartis Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 116. Cimed Industria de Medicamentos Product Offered
Table 117. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Cimed Industria de Medicamentos Main Business
Table 119. Cimed Industria de Medicamentos Latest Developments
Table 120. Cimed Industria de Medicamentos Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 121. Teva Product Offered
Table 122. Teva Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Teva Main Business
Table 124. Teva Latest Developments
Table 125. Teva Basic Information, Company Total Revenue (in $ million), Aciclovir Manufacturing Base, Sales Area and Its Competitors
Table 126. Wockhardt Product Offered
Table 127. Wockhardt Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Wockhardt Main Business
Table 129. Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Wockhardt Latest Developments
Table 131. Aliud Product Offered
Table 132. Aliud Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Aliud Main Business
Table 134. Aliud Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Aliud Latest Developments
Table 136. Takata Pharmaceutical Product Offered
Table 137. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Takata Pharmaceutical Main Business
Table 139. Takata Pharmaceutical Latest Developments
Table 140. Takata Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. L.E.T.I. Product Offered
Table 142. L.E.T.I. Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. L.E.T.I. Main Business
Table 144. L.E.T.I. Latest Developments
Table 145. L.E.T.I. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Shiono Kemikaru Product Offered
Table 147. Shiono Kemikaru Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Shiono Kemikaru Main Business
Table 149. Shiono Kemikaru Latest Developments
Table 150. Shiono Kemikaru Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Choseido Pharmaceutical Product Offered
Table 152. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Choseido Pharmaceutical Main Business
Table 154. Choseido Pharmaceutical Latest Developments
Table 155. Choseido Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 156. Apotex Product Offered
Table 157. Apotex Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 158. Apotex Main Business
Table 159. Apotex Latest Developments
Table 160. Apotex Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 161. Towa Yakuhin Product Offered
Table 162. Towa Yakuhin Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 163. Towa Yakuhin Main Business
Table 164. Towa Yakuhin Latest Developments
Table 165. Towa Yakuhin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 166. Nichi-Iko Pharmaceutical Product Offered
Table 167. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 168. Nichi-Iko Pharmaceutical Main Business
Table 169. Nichi-Iko Pharmaceutical Latest Developments
Table 170. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 171. Amneal Pharma Product Offered
Table 172. Amneal Pharma Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 173. Amneal Pharma Main Business
Table 174. Amneal Pharma Latest Developments
Table 175. Amneal Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 176. Pfizer Product Offered
Table 177. Pfizer Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 178. Pfizer Main Business
Table 179. Pfizer Latest Developments
Table 180. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 181. Orion Pharma Product Offered
Table 182. Orion Pharma Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 183. Orion Pharma Main Business
Table 184. Orion Pharma Latest Developments
Table 185. Orion Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 186. Laboratoires Servier Product Offered
Table 187. Laboratoires Servier Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 188. Laboratoires Servier Main Business
Table 189. Laboratoires Servier Latest Developments
Table 190. Laboratoires Servier Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 191. Sanofi Product Offered
Table 192. Sanofi Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 193. Sanofi Main Business
Table 194. Sanofi Latest Developments
Table 195. Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 196. Arrow Product Offered
Table 197. Arrow Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 198. Arrow Main Business
Table 199. Arrow Latest Developments
Table 200. Arrow Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 201. Mylan Product Offered
Table 202. Mylan Aciclovir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 203. Mylan Main Business
Table 204. Mylan Latest Developments
Table 205. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Aciclovir
Figure 2. Aciclovir Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Aciclovir Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Aciclovir Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Generic
Figure 7. Product Picture of Patent
Figure 8. Global Aciclovir Consumption Market Share by Type (2015-2020)
Figure 9. Global Aciclovir Value Market Share by Type (2015-2020)
Figure 10. Aciclovir Consumed in Hospital
Figure 11. Global Aciclovir Market: Hospital (2015-2020) (K Units)
Figure 12. Global Aciclovir Market: Hospital (2015-2020) ($ Millions)
Figure 13. Aciclovir Consumed in Drug Store
Figure 14. Global Aciclovir Market: Drug Store (2015-2020) (K Units)
Figure 15. Global Aciclovir Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Global Aciclovir Consumption Market Share by Application (2015-2020)
Figure 17. Global Aciclovir Value Market Share by Application (2015-2020)
Figure 18. Global Aciclovir Sales Market Share by Company in 2017
Figure 19. Global Aciclovir Sales Market Share by Company in 2019
Figure 20. Global Aciclovir Revenue Market Share by Company in 2017
Figure 21. Global Aciclovir Revenue Market Share by Company in 2019
Figure 22. Global Aciclovir Sale Price by Company in 2019
Figure 23. Global Aciclovir Consumption Market Share by Regions 2015-2020
Figure 24. Global Aciclovir Value Market Share by Regions 2015-2020
Figure 25. Americas Aciclovir Consumption 2015-2020 (K Units)
Figure 26. Americas Aciclovir Value 2015-2020 ($ Millions)
Figure 27. APAC Aciclovir Consumption 2015-2020 (K Units)
Figure 28. APAC Aciclovir Value 2015-2020 ($ Millions)
Figure 29. Europe Aciclovir Consumption 2015-2020 (K Units)
Figure 30. Europe Aciclovir Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Aciclovir Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Aciclovir Value 2015-2020 ($ Millions)
Figure 33. Americas Aciclovir Consumption Market Share by Countries in 2019
Figure 34. Americas Aciclovir Value Market Share by Countries in 2019
Figure 35. Americas Aciclovir Consumption Market Share by Type in 2019
Figure 36. Americas Aciclovir Consumption Market Share by Application in 2019
Figure 37. United States Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 38. United States Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Aciclovir Consumption Market Share by Countries in 2019
Figure 44. APAC Aciclovir Value Market Share by Regions in 2019
Figure 45. APAC Aciclovir Consumption Market Share by Type in 2019
Figure 46. APAC Aciclovir Consumption Market Share by Application in 2019
Figure 47. China Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 48. China Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 55. India Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 56. India Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Aciclovir Consumption Market Share by Countries in 2019
Figure 60. Europe Aciclovir Value Market Share by Countries in 2019
Figure 61. Europe Aciclovir Consumption Market Share by Type in 2019
Figure 62. Europe Aciclovir Consumption Market Share by Application in 2019
Figure 63. Germany Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 65. France Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 66. France Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 67. UK Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 68. UK Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Aciclovir Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Aciclovir Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Aciclovir Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Aciclovir Consumption Market Share by Application in 2019
Figure 77. Egypt Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Aciclovir Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Aciclovir Value Growth 2015-2020 ($ Millions)
Figure 87. Global Aciclovir Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Aciclovir Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Aciclovir Consumption 2021-2025 (K Units)
Figure 90. Americas Aciclovir Value 2021-2025 ($ Millions)
Figure 91. APAC Aciclovir Consumption 2021-2025 (K Units)
Figure 92. APAC Aciclovir Value 2021-2025 ($ Millions)
Figure 93. Europe Aciclovir Consumption 2021-2025 (K Units)
Figure 94. Europe Aciclovir Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Aciclovir Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Aciclovir Value 2021-2025 ($ Millions)
Figure 97. United States Aciclovir Consumption 2021-2025 (K Units)
Figure 98. United States Aciclovir Value 2021-2025 ($ Millions)
Figure 99. Canada Aciclovir Consumption 2021-2025 (K Units)
Figure 100. Canada Aciclovir Value 2021-2025 ($ Millions)
Figure 101. Mexico Aciclovir Consumption 2021-2025 (K Units)
Figure 102. Mexico Aciclovir Value 2021-2025 ($ Millions)
Figure 103. Brazil Aciclovir Consumption 2021-2025 (K Units)
Figure 104. Brazil Aciclovir Value 2021-2025 ($ Millions)
Figure 105. China Aciclovir Consumption 2021-2025 (K Units)
Figure 106. China Aciclovir Value 2021-2025 ($ Millions)
Figure 107. Japan Aciclovir Consumption 2021-2025 (K Units)
Figure 108. Japan Aciclovir Value 2021-2025 ($ Millions)
Figure 109. Korea Aciclovir Consumption 2021-2025 (K Units)
Figure 110. Korea Aciclovir Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Aciclovir Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Aciclovir Value 2021-2025 ($ Millions)
Figure 113. India Aciclovir Consumption 2021-2025 (K Units)
Figure 114. India Aciclovir Value 2021-2025 ($ Millions)
Figure 115. Australia Aciclovir Consumption 2021-2025 (K Units)
Figure 116. Australia Aciclovir Value 2021-2025 ($ Millions)
Figure 117. Germany Aciclovir Consumption 2021-2025 (K Units)
Figure 118. Germany Aciclovir Value 2021-2025 ($ Millions)
Figure 119. France Aciclovir Consumption 2021-2025 (K Units)
Figure 120. France Aciclovir Value 2021-2025 ($ Millions)
Figure 121. UK Aciclovir Consumption 2021-2025 (K Units)
Figure 122. UK Aciclovir Value 2021-2025 ($ Millions)
Figure 123. Italy Aciclovir Consumption 2021-2025 (K Units)
Figure 124. Italy Aciclovir Value 2021-2025 ($ Millions)
Figure 125. Russia Aciclovir Consumption 2021-2025 (K Units)
Figure 126. Russia Aciclovir Value 2021-2025 ($ Millions)
Figure 127. Spain Aciclovir Consumption 2021-2025 (K Units)
Figure 128. Spain Aciclovir Value 2021-2025 ($ Millions)
Figure 129. Egypt Aciclovir Consumption 2021-2025 (K Units)
Figure 130. Egypt Aciclovir Value 2021-2025 ($ Millions)
Figure 131. South Africa Aciclovir Consumption 2021-2025 (K Units)
Figure 132. South Africa Aciclovir Value 2021-2025 ($ Millions)
Figure 133. Israel Aciclovir Consumption 2021-2025 (K Units)
Figure 134. Israel Aciclovir Value 2021-2025 ($ Millions)
Figure 135. Turkey Aciclovir Consumption 2021-2025 (K Units)
Figure 136. Turkey Aciclovir Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Aciclovir Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Aciclovir Value 2021-2025 ($ Millions)
Figure 139. Greater Pharma Aciclovir Market Share (2018-2020)
Figure 140. Reman Drug Aciclovir Market Share (2018-2020)
Figure 141. LBS Labs Aciclovir Market Share (2018-2020)
Figure 142. Lex Ano Aciclovir Market Share (2018-2020)
Figure 143. Salutas Aciclovir Market Share (2018-2020)
Figure 144. GlaxoSmithKline Aciclovir Market Share (2018-2020)
Figure 145. Stada Nordic Aciclovir Market Share (2018-2020)
Figure 146. Novartis Aciclovir Market Share (2018-2020)
Figure 147. Cimed Industria de Medicamentos Aciclovir Market Share (2018-2020)
Figure 148. Teva Aciclovir Market Share (2018-2020)
Figure 149. Wockhardt Aciclovir Market Share (2018-2020)
Figure 150. Aliud Aciclovir Market Share (2018-2020)
Figure 151. Takata Pharmaceutical Aciclovir Market Share (2018-2020)
Figure 152. L.E.T.I. Aciclovir Market Share (2018-2020)
Figure 153. Shiono Kemikaru Aciclovir Market Share (2018-2020)
Figure 154. Choseido Pharmaceutical Aciclovir Market Share (2018-2020)
Figure 155. Apotex Aciclovir Market Share (2018-2020)
Figure 156. Towa Yakuhin Aciclovir Market Share (2018-2020)
Figure 157. Nichi-Iko Pharmaceutical Aciclovir Market Share (2018-2020)
Figure 158. Amneal Pharma Aciclovir Market Share (2018-2020)
Figure 159. Pfizer Aciclovir Market Share (2018-2020)
Figure 160. Orion Pharma Aciclovir Market Share (2018-2020)
Figure 161. Laboratoires Servier Aciclovir Market Share (2018-2020)
Figure 162. Sanofi Aciclovir Market Share (2018-2020)
Figure 163. Arrow Aciclovir Market Share (2018-2020)
Figure 164. Mylan Aciclovir Market Share (2018-2020)
Reason to Buy